Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pepke-Zaba

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
The European Respiratory Journal|September 2, 2008
Current differences in referral patterns for pulmonary endarterectomy in the UKM Toshner, J Suntharalingam, K Goldsmith, et al.
Health Technology Assessment (Winchester, England)|October 30, 2009
Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluationY-F Chen, S Jowett, P Barton, et al.
The New England Journal of Medicine|May 30, 1991
Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung diseaseA T Dinh-Xuan, T W Higenbottam, C A Clelland, et al.
The European Respiratory Journal|October 3, 2008
Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertensionR Condliffe, D G Kiely, J S R Gibbs, et al.
The European Respiratory Journal|December 7, 2007
Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertensionJ Suntharalingam, K Goldsmith, V van Marion, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
The European Respiratory Journal|September 2, 2008
Current differences in referral patterns for pulmonary endarterectomy in the UKM Toshner, J Suntharalingam, K Goldsmith, et al.
Health Technology Assessment (Winchester, England)|October 30, 2009
Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluationY-F Chen, S Jowett, P Barton, et al.
The New England Journal of Medicine|May 30, 1991
Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung diseaseA T Dinh-Xuan, T W Higenbottam, C A Clelland, et al.
The European Respiratory Journal|October 3, 2008
Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertensionR Condliffe, D G Kiely, J S R Gibbs, et al.
The European Respiratory Journal|December 7, 2007
Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertensionJ Suntharalingam, K Goldsmith, V van Marion, et al.
Pageof 4